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There was no significant decrease in 
cross sectional area of the pectoralis 
in post-surgical patients over a one 
year lung cancer treatment period.
INTRODUCTION
-Analysis of iliopsoas cross-sectional area, a non-
invasive surrogate measure for sarcopenia in 
patients with cancer has been associated with 
survival.
-More accessible in thoracic cancer, could  
measuring the cross-sectional area of the 
pectoralis be as accurate?
METHOD
• N=44 (13 had a complete set of 
imaging)
• 12/13 stage 1 or 2 and had 
undergone lobectomy
• 10/13 were ECOG performance 
grade 0 at diagnosis
RESULTS
-The mean iliopsoas area at diagnosis 
was 8.17cm2. The mean pectoralis area 
at diagnosis was 14.5cm2.
-8 out of 13 subjects had a decrease in 
mean pectoralis area over 6 months and 
6 subjects had a decrease at 12 months. 
These results were not statistically 
significant.
DISCUSSION
This could be because of the initial high 
performance status of our sample, the 
small size, or sarcopenia occurs 
comorbidly with presentation. 
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